ARCHIVES

Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now

This article is from The Cancer Letter archive.

Vol. 09 No. 46 | December 2, 1983

Download PDF Visit The Full Archive

Related Articles

Blumenthal Says Action Plan To Issue “New Priority Areas”

October 24, 1996

ICF Clement Joins Dynalectron In FCRF

January 9, 1987

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

Dingell: “Unable To Vouch” For Staff Report On NCI’s Gallo

February 10, 1995

Varmus calls NIH Structure “Cumbersome,” Suggests Streamlining Based On science

August 6, 1999